Wardwizard Healthcare Ltd
₹ 43.2
4.98%
11 Dec
- close price
About
Incorporated in 1985, Wardwizard Healthcare
Ltd is in the business of Consultancy and other services[1]
Key Points
- Market Cap ₹ 1.06 Cr.
- Current Price ₹ 43.2
- High / Low ₹ 43.2 / 19.8
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE -58.7 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.02 | 0.02 | 0.01 | 0.07 | 0.07 | 0.03 | 0.23 | 0.17 | 0.14 | 0.11 | 0.42 | 0.39 | |
| 0.01 | 0.03 | 0.06 | 0.10 | 0.07 | 0.07 | 0.11 | 0.28 | 0.17 | 0.17 | 0.42 | 2.20 | 2.29 | |
| Operating Profit | 0.01 | -0.01 | -0.04 | -0.09 | 0.00 | 0.00 | -0.08 | -0.05 | 0.00 | -0.03 | -0.31 | -1.78 | -1.90 |
| OPM % | 50.00% | -50.00% | -200.00% | -900.00% | 0.00% | 0.00% | -266.67% | -21.74% | 0.00% | -21.43% | -281.82% | -423.81% | -487.18% |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.03 | 0.55 | 0.42 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.49 | 0.42 |
| Profit before tax | 0.01 | -0.01 | -0.04 | -0.09 | 0.00 | 0.00 | -0.08 | -0.05 | -0.01 | -0.03 | -0.42 | -2.82 | -2.30 |
| Tax % | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.14% | -3.90% | |||
| 0.00 | -0.01 | -0.04 | -0.09 | 0.00 | 0.00 | -0.08 | -0.05 | -0.01 | -0.03 | -0.45 | -2.71 | -2.34 | |
| EPS in Rs | |||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 70% |
| 3 Years: | 35% |
| TTM: | 77% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -92% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 129% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Reserves | 0.11 | 0.09 | 0.05 | -0.04 | -0.03 | -0.03 | -0.11 | -0.16 | -0.17 | -0.20 | -0.64 | -3.36 | -3.80 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.80 | 10.44 | 3.02 | |
| -0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | 0.07 | 1.41 | 1.17 | |
| Total Liabilities | 0.35 | 0.35 | 0.30 | 0.22 | 0.23 | 0.23 | 0.15 | 0.12 | 0.10 | 0.07 | 0.48 | 8.74 | 0.64 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 7.28 | 0.21 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.35 | 0.35 | 0.30 | 0.22 | 0.23 | 0.23 | 0.15 | 0.12 | 0.10 | 0.07 | 0.15 | 1.46 | 0.43 | |
| Total Assets | 0.35 | 0.35 | 0.30 | 0.22 | 0.23 | 0.23 | 0.15 | 0.12 | 0.10 | 0.07 | 0.48 | 8.74 | 0.64 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.01 | -0.03 | -0.06 | -0.06 | 0.00 | -0.09 | -0.06 | 0.00 | -0.05 | -0.01 | -0.37 | -1.63 | |
| 0.02 | 0.02 | 0.02 | 0.05 | 0.07 | 0.01 | 0.07 | -0.01 | 0.05 | 0.00 | 0.00 | -0.01 | |
| -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | 1.65 | |
| Net Cash Flow | 0.00 | -0.01 | -0.04 | -0.02 | 0.07 | -0.08 | 0.01 | -0.01 | 0.01 | -0.01 | 0.00 | 0.01 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 730.00 | 730.00 | 730.00 | 0.00 | 0.00 | 365.00 | 365.00 | 0.00 | 64.41 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 182.50 | 30.42 | 648.89 | |||||||||
| Days Payable | 0.00 | 0.00 | 4,258.33 | |||||||||
| Cash Conversion Cycle | 730.00 | 730.00 | 730.00 | 0.00 | 0.00 | 365.00 | 547.50 | 30.42 | 64.41 | 0.00 | 0.00 | -3,609.44 |
| Working Capital Days | 730.00 | 365.00 | 547.50 | -365.00 | -104.29 | 312.86 | 365.00 | -31.74 | 21.47 | 78.21 | 165.91 | -912.50 |
| ROCE % | 2.82% | -2.86% | -12.50% | -35.29% | 0.00% | 0.00% | -44.44% | -43.48% | 0.00% | -46.15% | -169.57% | -58.66% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 Nov - Newspaper Publication for Standalone Unaudited Financial Results for the quarter ended 30th September 2025 as per Regulation 47 and Regulation 30 of SEBI (LODR)2015
-
Intimation Under Regulation 30 (5) Of The SEBI (LODR Regulations), 2015 ('Listing Regulations').
14 Nov - Board approved changes to authorized KMPs: Gaurav J. Gupte, Mittalben Patel, Rajbala Kiroriwal, effective 14 Nov 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
14 Nov - Appointed Mr. Yuvraj Priyadarshi as CEO effective 14-Nov-2025; KMP profile included.
-
Outcome Of Board Meeting - Submission & Approval Of Un-Audited Financial Results (Standalone) Of The Company For The Second Quarter And Half Yearly Ended 30Th September 2025(2025-26)
14 Nov - Wardwizard Healthcare approved unaudited standalone Q2 and H1 results for period ended 30 Sep 2025.
-
Board Meeting Outcome for Outcome Of Meeting Of Board Of Wardwizard Healthcare Limited (Formerly Known As Ayoki Merchantile Limited) Held On Friday, 14Th November 2025.
14 Nov - Unaudited Q2/H1 results for Sep 30, 2025; CEO Yuvraj Priyadarshi appointed 14 Nov 2025; stakeholder committee reconstituted.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
WHL provides Healthcare Services and Actvities for Ayurveda Practitioners. It is in the business of exploring various business opportunities in medical treatment, multi-speciality hospitals, medical educational institutions, research/technology labs, healthcare, pharmacy stores, ambulance services, home care, etc.